Cargando…
Two-Stage Single-Arm Trials Are Rarely Analyzed Effectively or Reported Adequately
PURPOSE: Two-stage single-arm designs have historically been the most common design used in phase II oncology. They remain a mainstay today, particularly for trials in rare subgroups. Consequently, it is imperative such studies be designed, analyzed, and reported effectively. We comprehensively revi...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691516/ https://www.ncbi.nlm.nih.gov/pubmed/34950839 http://dx.doi.org/10.1200/PO.21.00276 |